Last reviewed · How we verify
Dextrose 5% and Lidocaine
At a glance
| Generic name | Dextrose 5% and Lidocaine |
|---|---|
| Sponsor | National and Kapodistrian University of Athens |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery (PHASE4)
- Effects of Dextrose Prolotherapy in Rotator Cuff Disease (NA)
- Comparison of Injection Techniques in Carpal Tunnel Syndrome (PHASE4)
- Comparison of Prolotherapy and Rehabilitation Treatments in Low Back Pain (CPRTLBP) (NA)
- Spinal Anesthesia For Enhanced Recovery After Liver Surgery (NA)
- A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis (PHASE1, PHASE2)
- Perineural Prolotherapy in Chronic Knee Osteoarthritis Pain. (NA)
- Comparison of the Effectiveness of Dextrose Prolotherapy and Extracorporeal Shock Wave Therapy (ESWT) in Plantar Fasciitis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dextrose 5% and Lidocaine CI brief — competitive landscape report
- Dextrose 5% and Lidocaine updates RSS · CI watch RSS
- National and Kapodistrian University of Athens portfolio CI